It’s a done deal for Novartis stake

GlaxoSmithKline CEO Emma Walmsley on Tuesday agreed to pay $13bn for Novartis’s stake in the companies’ consumer healthcare joint venture, which owns brands such as Sensodyne toothpaste and Nicorette nicotine patches. Novartis gained the right to force a purchase of its 37% holding in early March.